MedTrace Logo

Will Restasis Eye Drops Increase Your Chance of Having a Successful Surgery?

NCT00405431 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2016-11-22

No results posted yet for this study

Summary

The purpose of this study is to determine whether reducing inflammation of the surface of the eye with topical Restasis after glaucoma surgery will improve surgical outcomes and increase patient comfort.

Conditions

Interventions

DRUG

Restasis

1 drop in study eye twice a day X 6 months

DRUG

Endura (artificial tears)

1 drop in study eye twice a day X 6 months

Sponsors & Collaborators

  • Allergan

    collaborator INDUSTRY

  • Wills Eye

    lead OTHER

Principal Investigators

  • Marlene R. Moster, MD · Wills Eye Glaucoma Research Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-03-31
Primary Completion
2005-06-30
Completion
2007-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00405431 on ClinicalTrials.gov